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A balanced interaction between the homeostatic mechanisms of mother and the devel-
oping organism during pregnancy and in early neonatal life is essential in order to ensure 
optimal fetal development, ability to respond to various external and internal challenges, 
protection from adverse programming, and safeguard maternal care availability after 
parturition. In the majority of pregnancies, this relationship is highly effective resulting in 
successful outcomes. However, in a number of pathological settings, perturbations of the 
maternal homeostasis disrupt this symbiosis and initiate adaptive responses with unpre-
dictable outcomes for the fetus or even the neonate. This may lead to development of 
pathological phenotypes arising from developmental reprogramming involving interaction 
of genetic, epigenetic, and environmental-driven pathways, sometimes with acute conse-
quences (e.g., growth impairment) and sometimes delayed (e.g., enhanced susceptibility 
to disease) that last well into adulthood. Most of these adaptive mechanisms are activated 
and controlled by hormones of the hypothalamo-pituitary adrenal axis under the influ-
ence of placental steroid and peptide hormones. In particular, the hypothalamic peptide 
corticotropin-releasing hormone (CRH) plays a key role in feto-maternal communication 
by orchestrating and integrating a series of neuroendocrine, immune, metabolic, and 
behavioral responses. CRH also regulates neural networks involved in maternal behavior 
and this determines efficiency of maternal care and neonate interactions. This review 
will summarize our current understanding of CRH actions during the perinatal period, 
focusing on the physiological roles for both mother and offspring and also how external 
challenges can alter CRH actions and potentially impact on fetus/neonate health.
Keywords: corticotropin-releasing hormone, placenta, hypothalamo-pituitary adrenal axis, homeostasis, 
glucocorticoids, allostasis, neurodevelopment, metabolism
inTRODUCTiOn
The prenatal period represents an immensely challenging phase for the maternal physiology, as it 
requires continuous adaptive changes to accommodate functional impact of new organs such as the 
placenta and also increasing and variable demands in response to the new organism’s growth, expan-
sion, and development (1). These changes are also important as they prepare the mother for labor 
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and delivery and later maternal care. A selective redistribution of 
the fuels used by mother and fetus allows the pregnant mother 
to preferentially use fat for fuel, preserving the available glucose 
and amino acids for the fetus and minimizing protein catabolism. 
This inter-dependent sharing of metabolic resources and nutrient 
energy substrate availability might influence length of gestation 
and pregnancy outcomes. In this context, preterm onset of labor 
may represent a maternal adaptation to limit the metabolic cost 
of a pregnancy threatened by adverse conditions, or alternatively 
a fetal adaptation to an unfavorable intrauterine environment.
The intrauterine conditions in which the developing fetus 
grows have an important role in regulating the function and pre-
serving integrity of its physiological systems later in life. Studies 
confirm that environmental perturbations altering the intrauter-
ine availability of nutrients, oxygen, and hormones program fetal 
development and ultimately offspring physiological outcomes 
(2–11); thus, the ability to mount appropriate adaptive responses 
and counteract adversity is essential for pregnancy success and to 
minimize the cost on organism’s health. Lessons from mamma-
lian evolutionary biology and current developmental plasticity 
concepts suggest that a key player in these pregnancy-induced 
changes is the hypothalamo-pituitary adrenal (HPA) axis, which 
regulates central and peripheral homeostatic adaptive responses 
to stress (12, 13). The HPA axis finely tunes the symbiotic relation-
ship of mother and developing fetus and also determines length 
of gestation and timing of onset of mammalian parturition. 
Development of such coordinated responses is crucial since the 
developing fetus decodes and integrates environmental signals 
partly via activation of the same biological systems that in mature 
organisms mediate adaptation and central and peripheral bio-
logical and behavioral responses to endogenous and exogenous 
stressors (e.g., the maternal-placental-fetal neuroendocrine 
systems). Emerging data also identify the HPA axis as a key 
player in the development of the progeny especially the first few 
months outside the intrauterine environment, a critical period 
for development with considerable interactions between genetics 
and environment. However, this asymmetric interaction between 
two organisms in different developmental stages that requires 
continuous adjustment is poorly understood. This review will 
examine the current evidence on hormonal responses of the HPA 
axis initiated by the hypothalamic peptide corticotropin-releasing 
hormone (CRH) and the mechanisms involved in establishing an 
effective mother–progeny symbiosis in the prenatal environment 
and later during the early neonatal period, the effects of which 
shape the organism’s health and behavior throughout life.
MATeRnAL HPA AXiS AnD CRH
Pregnancy is characterized by dramatic changes in the feto-
maternal stress-hormonal system that impacts on the maternal 
HPA axis function. The anthropoid primate placenta appears 
to be unique in producing CRH. There are at least two patterns 
of secretion of placental CRH (pCRH) across gestation among 
anthropoids. Certain monkeys (Papio and Callithrix) have an 
early-to-mid gestational peak, followed by a steady decline to 
a plateau level, with a possible further rise near parturition. 
By contrast, humans and great apes placenta secretes large 
quantities of pCRH into the maternal bloodstream during 
the second and third trimesters of pregnancy and this expo-
nential rise peaks at parturition (14–17). Interestingly, unlike 
the hypothalamic peptide, pCRH secretion is augmented by 
cortisol, thus providing a unique positive feedback loop exten-
sion to the feto-maternal stress axis that sustains high levels 
of CRH secretion throughout pregnancy (Figure 1A). Elevated 
maternal cortisol at 15 weeks of gestation predicts elevated CRH 
at 31 weeks, suggesting that elevated cortisol early in pregnancy 
can exert priming effects on fetal/pCRH system (18).
Both human and rodent feto-maternal tissues have “in-built” 
defense mechanisms that protect the fetus from exposure to 
high levels of maternal glucocorticoids and detrimental effects 
of programming. For example, failure of the 11β-hydroxysteroid 
dehydrogenase 2 (11β-HSD2) barrier to prevent fetal overexpo-
sure is associated with pregnancy complications such as lower 
birth weight and shorter gestation at delivery (19–21) as well as 
long-term consequences for the offspring, including resetting of 
the HPA axis and susceptibility to neurodevelopmental problems 
and cardio-metabolic disease (22–26).
As pregnancy progresses toward term, maternal hypotha-
lamic production of CRH is downregulated and, thus, the 
responsiveness of the maternal HPA axis to both physiological 
and psychological stress is attenuated, a critical adaptation event 
that provides protection for mother and fetus from the effects of 
adversity (27–30). It is conceivable that women who fail to show 
the expected decrease in HPA reactivity to stress and anxiety are 
at increased risk of complications such as for preterm delivery 
(31–33), although assessment of anxiety during pregnancy is 
challenging and can be difficult to distinguish between “normal” 
pregnancy symptoms, which are common during pregnancy, 
and atypical somatic complaints such as fatigue, loss of energy, 
appetite, and sleep changes, which may be related to depression 
or anxiety.
In the postpartum period, following delivery of the placenta 
and a sharp drop in pCRH and steroid hormone levels, maternal 
plasma cortisol levels fall and the function of the mother’s HPA 
axis and most homeostatic systems gradually return to its pre-
pregnant state. Due the prolonged effects of glucocorticoids, 
the HPA axis is relatively hypo-responsive to dexamethasone 
suppression for up to 3 weeks postpartum, and recovery of CRH 
secretion is evident by 12  weeks postpartum (34, 35). Altered 
HPA responses to pregnancy may influence later maternal mental 
health and mood disturbances, ultimately compromising quality 
of maternal care in the postpartum period (36–38).
CRH–HPA AXiS AnD MeTABOLiC FUeL 
DiSTRiBUTiOn BeTween MOTHeR AnD 
FeTUS
To meet the increased energy demands of mother and fetus, 
food intake increases in pregnancy by resetting central appetite-
control mechanisms (39), involving development of central 
leptin resistance and differential regulation of central actions of 
other orexigenic and anorexigenic hormones and neurosteroids 
that shift the balance toward increased appetite, food intake and 
FigURe 1 | (A) The first step of mammalian hypothalamo-pituitary adrenal (HPA) axis activation in response to psychological or physical stressors involves activation 
of neurosecretory corticotropin-releasing hormone (CRH) neurons in the hypothalamic paraventricular nucleus. CRH and AVP released into the hypophysial portal 
blood system stimulate adrenocorticotropic hormone (ACTH) release from anterior pituitary corticotrophs and, in turn, the adrenal to secrete glucocorticoids 
(corticosterone in rodents) into the bloodstream. Cortisol tightly controls HPA activity by feeding back to glucocorticoid receptors (GR) and mineralocorticoid 
receptors (MR) in the pituitary and hypothalamus to turn-off CRH release and its own secretion. In humans and higher primate pregnancy, placenta secretes large 
quantities of CRH into the maternal bloodstream during the second and third trimesters of pregnancy. Placental CRH secretion is augmented by cortisol, thus 
providing a unique positive feedback loop extension to the feto-maternal stress axis that sustains high levels of CRH secretion throughout pregnancy. (B) In 
response to increased energy demands of mother and fetus, food intake increases in pregnancy by resetting central appetite-control mechanisms. A key molecular 
event appears to be altered leptin signaling and development of central leptin resistance. This is primarily due to decreased expression of the Ob-Rb leptin receptor 
in the ventromedial hypothalamus and reduced signaling activity despite increased concentration of circulating leptin as a result of expansion of the adipose tissue 
with contribution from placental secretion. This is coupled with differential regulation of central actions of other orexigenic and anorexigenic hormones and 
neurosteroids, such as CRH, NPY and AgRP, progesterone, and allopregnanolone that shift the balance toward increased appetite and food intake and fat storage 
and decreased thermogenesis. These mechanisms ensure that there are sufficient nutrients for the fetus, sufficient energy for the extra metabolic strain on the 
mother, and a surplus of energy that can be stored as fat in preparation for lactation.
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fat storage, and decreased thermogenesis (39, 40) (Figure 1B). 
These mechanisms ensure that there are sufficient nutrients for 
the fetus, sufficient energy for the extra metabolic strain on the 
mother, and a surplus of stored energy. Changes in maternal 
metabolic state are directly transmitted to the fetus: for example, 
maternal hyperglycemia in pregnant women induces hypergly-
cemia and elevated insulin levels in the fetus, thus increasing the 
risk for complications in infancy and later life (41). Moreover, 
Barker and colleagues (42) established that derangement of fetal 
growth trajectories and neonatal development are directly linked 
to maternal nutritional status, suggesting that both intra- and 
extra-uterine environment work as a continuum to determine the 
metabolic status of the progeny.
Homeostatic challenges such as prenatal maternal stress can 
program offspring obesity and metabolic disease risk in adult-
hood (43–46). This involves pathogenic mechanisms reorgan-
izing immature neural pathways at the hypothalamus (47–49). 
In this pathological setting, a possible indirect role for CRH in 
programming homeostasis of energy balance and metabolism at 
adulthood has been suggested since changes in growth trajectories 
associated with altered pCRH levels and reduced fetal growth and 
size at birth are predictors of childhood and adult adiposity (50). 
In addition, a positive association has been identified between 
elevated CRH at 30 weeks of gestation and a phenotypic pattern 
of an early small body size followed by a rapid catch-up growth 
(51), previously associated with early development of adiposity 
and insulin resistance (52). Higher circulating levels of CRH also 
correlate with increased central adiposity (53) and increased 
levels of adiponectin probably as a compensatory mechanism to 
improve insulin sensitivity in childhood (54).
Maternal obesity, another type of metabolic challenge, 
increases risk of fetus developing obesity, insulin resistance, 
and metabolic syndrome (49, 55–57). It is possible that during 
maternal obesity, CRH, up-regulated by maternal cortisol, might 
act as an autocrine/paracrine regulator to increase glucose uptake 
and facilitate transfer from the mother to the fetus through the 
upregulation of GLUT1 in the placenta (58). Moreover, CRH 
could interact with placental and peripheral systems to enhance 
the production of pro-inflammatory cytokines and pro-inflam-
matory factors that can reach the fetus. Enhanced secretion from 
the placenta of cytokines and adipokines are linked to a number 
of pathological states, including gestational diabetes, hyperten-
sion, and intrauterine growth restriction (59).
CRH–HPA AXiS in FeTAL 
neURODeveLOPMenT
Pregnancies complicated by pathological perturbations leading 
to poor fetal outcomes, including premature labor, hypertension, 
and intrauterine fetal growth retardation (IUGR) are associated 
with increased CRH production by the placenta and secretion into 
maternal blood (60–63). The diverse placental signaling mecha-
nisms regulated by CRH suggest that elevated CRH controls the 
placental “surveillance and response” system so that the fetus can 
detect threats to survival and adjust its developmental trajectory 
(64–67) (Figure 2A). When stress signals (e.g., cortisol) from the 
maternal environment are detected by the fetoplacental unit, the 
“placental clock” may adapt by altering rate of synthesis of the 
“master” stress hormone, CRH. The rapid increase in circulating 
CRH might initiate mechanisms to regulate myometrial contrac-
tile machinery and the onset of labor (68, 69). In parallel, fetal 
developmental trajectories are adjusted to accelerate maturation 
of critical organs such as modification of its nervous system to 
ensure survival in a potentially hostile environment (70, 71).
Evidence point toward delayed fetal maturation and impaired 
cognitive performance during infancy resulting in decreased 
brain volume in areas associated with range of cognitive func-
tions, including learning and memory in children (72). These 
fetal neurobiological adjustments on brain development might 
involve direct effects of CRH, which can exert neurotoxic effects 
on hippocampal neurons especially in the immature hippocam-
pus (73–75). In addition, elevated concentrations of CRH may 
affect directly the developing brain through changes in neuronal 
sensitivity to CRH actions especially in amygdala and hippocam-
pus, two key regions involved in mediating the central stress 
response and integrating information regarding “emotional” or 
“cognitive” stress (76, 77).
The impairment in neurodevelopment associated with altered 
levels of CRH can be detected early during in utero life. Studies 
assessing neurological integrity during pregnancy suggest that 
exposure to lower levels of CRH early in gestation may be associ-
ated with greater maturity of the fetal central nervous system 
and accelerated neurological development (70). Moreover, fetal 
exposure to increased levels of maternal cortisol at 15 weeks and 
at 19 weeks of gestation and increased levels of CRH at 31 weeks 
gestation are associated with a significant decrease in newborn 
physical and neuromuscular maturation. These neonatal measures 
of maturation reflect altered neurological development detected 
with magnetic resonance imaging in newborns, including basal 
ganglia and white matter lesions, as well as motor abnormalities 
that persist in early childhood (71).
CRH–HPA AXiS AnD THe inTeRACTiOn 
BeTween MOTHeR AnD THe neOnATe
After parturition, the connection between neonate and mother 
shifts to a new physiological equilibrium from a complete physi-
ological dependence to one where two separate individual organ-
isms are in close physical and behavioral contact; this biological 
relationship can also be influenced by environmental adversity. 
Young mammals still depend upon the mother for nutrition and 
physical stimulation as they mature toward complete nutritional 
independence. Any disruption of the maternal-neonate postnatal 
interaction by early life events can also induce programming 
responses with long-lasting consequences. The CRH system is 
recognized as key for coordinating or even directly inducing 
adaptations that support the organism to defend against stressful 
situations such as deterioration of quality of maternal care to 
maintain homeostasis and survival. However, the immaturity of 
the CRH system in the newborn makes it vulnerable and suscep-
tible to develop functional abnormalities and ultimately disease 
later in life (78–80).
FigURe 2 | (A) Corticotropin-releasing hormone (CRH) controls the placental “surveillance and response” system so that the fetus can detect threats to survival and 
adjust its developmental trajectory. The placenta employs an intricate network of sensors to decode signals from the maternal environment and prepare the fetus for 
postnatal survival. Disruption of these sensors might have detrimental effects on fetal neurodevelopment. The “CRH placental clock” might be part of this 
surveillance and response system: when stress signals such as cortisol from the maternal environment are detected by the fetal/placental unit, the “placental clock” 
may adapt by altering rate of synthesis of the “master” stress hormone, CRH. The rapid increase in circulating CRH might initiate mechanisms targeting maternal 
tissues to regulate myometrial contractile machinery and the onset of labor. In parallel, fetal developmental trajectories are adjusted to accelerate maturation of 
critical organs such as modification of its nervous system to ensure survival in a potentially hostile environment. (B) Maternal behaviors resulting in decreased 
hypothalamo-pituitary adrenal (HPA) axis response to stress in adulthood are most likely driven by enhanced feedback sensitivity of CRH to glucocorticoids in the 
hippocampus. This involves epigenetic modifications of NR3C1, the gene encoding glucocorticoid receptors, in the brain increasing its mRNA expression via 
mechanisms that promote binding of the transcription factor nerve growth factor-inducible factor A (NGFI-A). This interaction involves a thyroid-hormone-dependent 
increase in serotonin (5-HT) activity at 5-HT7 receptors and the subsequent activation of cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) 
pathway. Hippocampal CRH gene expression is also regulated by maternal care and early life stress through similar epigenetic mechanisms. Similarly, increased 
histone H3 acetylation and decreased cytosine methylation in the promoter region of CRH gene in hippocampal CA1 layer promote mRNA expression of the 
neuropeptide. One potential mechanism that enables positive environmental signals (induced by augmented maternal care) to influence transcription of the CRH 
gene in the offspring hypothalamus involves increased hypothalamic levels of the repressor neuron-restrictive silencer factor (NRSF). NRSF represses the 
transcription of the CRH gene by binding in the regulatory region of the CRH gene, an epigenetic regulation that persists into adulthood.
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In rodents, the period of HPA axis immaturity from birth 
to the second postnatal week is characterized by a stress hypo-
responsive period. This has been attributed mainly to glucocor-
ticoid receptors (GR): reduced functionality in the hypothalamic 
paraventricular nucleus (PVN) would enhance expression of 
CRH (81, 82), although enhanced GR negative feedback in the 
pituitary, would diminish stress response of newborn animals 
(83). Similar diminished stress response is observed in humans 
during the first year of life (84) and in non-human primates that 
also respond to quality of maternal care (85).
Lactation and milk infusion can have beneficial effects on 
HPA axis activity and maintain low concentrations of circulating 
corticosterone even in the mother’s absence (80). Acquisition 
of nutrients during lactation represents a direct bond between 
infant and mother in early life. Milk composition can also affect 
various homeostatic parameters, such as growth rate, metabo-
lism, neurodevelopment, and stress reactivity. It is considered as 
the main vehicle by which glucocorticoids pass from the mother 
to the offspring (86, 87) and influence the expression of neonatal 
CRH and ultimately the normal maturation of the HPA axis 
(88). Thus, maternal diet plays a key role in the type of nutrients 
that are transferred to the neonate and HPA biological settings; 
consumption of a high fat diet during pregnancy and/or lactation 
periods increases not only the fat content of the milk but also 
the corticosterone plasma levels in dams. This would program 
the offspring not only toward overweight in the adulthood but 
also increases corticosterone circulating levels and the risk of 
metabolic syndrome (89).
CRH AnD MeTABOLiC ADJUSTMenTS 
UnDeR POSTnATAL STReSS
Disruption of maternal care promotes distinct endocrine, 
metabolic, and behavioral phenotypic responses in the offspring. 
Emerging pieces of evidence suggest an early life stress-induced 
interaction between the HPA axis and energy balance mecha-
nisms leading to deranged metabolic profile later in life associated 
with insulin resistance. An interesting hypothesis identifies liver 
11β-HSD1–HPA axis interactions as a potential pathway in early-
life stress-mediated metabolic disturbances, particularly insulin 
sensitivity, glucose metabolism and lipid synthesis, and mobili-
zation possibly involving changes in glucocorticoid metabolism 
and signaling (90).
Maternal behaviors resulting in highly nurtured pups that 
exhibit decreased HPA axis response to stress in adulthood are 
most likely driven by enhanced feedback sensitivity to glucocor-
ticoids in the hippocampus. This likely involves epigenetic modi-
fications of NR3C1, the gene encoding GR, in the brain increasing 
its mRNA expression (91, 92) (Figure 2B). It is proposed that a 
global epigenetic signature of early life experience is maintained 
across species and centered around GR gene regulation, which 
targets specific regulatory regions such as gene promoters, par-
ticularly those of the protocadherin α, β, and γ gene families (93).
By contrast, a disrupted maternal care during the hypo-
responsive period could also impact gene expression by opposing 
epigenetic mechanisms (79, 94). Postmortem studies on human 
brain samples from suicide victims with reported childhood 
neglect/abuse support this theory and showed that methylation of 
the NR3C1 promoter is increased and expression of GR reduced 
in hippocampal tissue (95).
Hypothalamic CRH gene expression is also regulated by 
maternal care and early life stress through similar epigenetic 
mechanisms (96). Similarly, increased histone H3 acetylation 
and decreased cytosine methylation in the promoter region of 
CRH gene in hippocampal CA1 layer promote mRNA expression 
of the neuropeptide induced by the same stress paradigm (97). 
Interestingly, environmental enrichment after weaning reverses 
both the epigenetic upregulation of the CRH expression and 
the hippocampal synaptic dysfunction of maternally separated 
animals (97), indicating epigenetic flexibility in this system influ-
enced also by positive stimulus. One potential mechanism that 
enables positive environmental signals to influence transcription 
of the CRH gene in the offspring hypothalamus involves the 
repressor neuron-restrictive silencer factor (98).
A number of maternal deprivation experimental protocols 
that disrupt maternal-offspring interaction especially during the 
lactation period and increase the stressful environment of the 
pups identified altered functionality of the CRH system. These 
are associated with long-lasting increases in food intake, body 
weight, and metabolic syndrome risk. Molecular defects identi-
fied include decreased expression of CRH-R2 in the ventrome-
dial hypothalamus (VMH) especially in the absence of sensory 
stimuli (99), a receptor subtype that elicits the anorexigenic effect 
of CRH and urocortins (100). Lack of maternal care, milk inges-
tion and hypothermia, lead to increased corticosterone levels 
(101, 102) and chronically alter the glucocorticoid feedback, 
maintaining increased synthesis and cerebro-spinal fluid (CSF) 
concentrations of CRH, as well as basal corticosterone concentra-
tions until adulthood (103, 104). In some examples of impact of 
neonatal stress in adulthood, adult male offspring show increased 
CRH expression in the hypothalamus and hippocampus, 
memory deficits, dendritic atrophy, and altered adult hippocam-
pal neurogenesis (105), whereas female adults show increased 
corticosterone release in response to stress, anxiety, behavior, and 
preference to eat palatable food compared to control rats (106). 
Such a hyperphagic behavior of animals experiencing maternal 
separation (MS) early in life could be caused by increased hypo-
thalamic expression of NPY (107) associated with a decreased 
signaling of CRH-R2 receptors in the PVN. Adult MS animals 
show decreased behavioral and biochemical response to an intra-
PVN injection of exogenous urocortin 2, suggesting its altered 
functionality might be attributable to a chronic stress exposure 
(108). The levels of CRH-R2 in the VMH are under the control 
of maternal stimuli in early postnatal life (99), thus, maternal 
care-driven mechanisms might influence CRH-R2 function in 
PVN. Similar to animal findings, increased basal glucocorticoid 
levels, altered glucocorticoid feedback and presence of higher 
CSF concentrations of CRH are observed in humans subjected 
to emotional neglect and particularly to parental stress during 
childhood (109–111). This hyperactivation of the HPA axis 
system promotes the development of obesity and metabolic syn-
drome (112, 113) because of the influence of glucocorticoids on 
orexigenic hypothalamic signals, predominantly stimulating the 
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drive for hypercaloric foods (112, 114, 115). Also, environmental 
adversity associated with low socioeconomic status during child-
hood is a predictor of metabolic risk factors, including increased 
body mass index and altered insulin sensitivity in adults with 
parental loss and neglect during infancy; all associated with 
higher basal cortisol levels (79, 115).
COnCLUSiOn
Interactions of the fetus/neonate with the mother are emerging 
as critical for organism’s development that determines resilience 
to adversity across the lifespan. In the developing organism, 
CRH and the HPA axis appear particularly sensitive to exposure 
to signals from the maternal environment, either physical or 
behavioral responses to stress or disease. Their ability to influ-
ence the activity of molecular switches and mechanisms with 
key roles in developmental outcomes identifies a critical need to 
maintain tight homeostatic control of these mechanisms since 
deranged adaptive responses have devastating consequences 
either directly or through permanent programming that influ-
ence disease susceptibility. Recognizing and characterizing these 
HPA adaptations (or mal-adaptations) offer a promising strategy 
for development of novel preventative or therapeutic approaches.
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